North America’s medical devices industry saw a drop of 2.78% in deal activity during February 2022

North America’s medical devices industry saw a drop of 2.78% in deal activity during February 2022, when compared with the last 12-month average, led by Anthem, Blue Venture Fund, Deerfield ManagementLP, Fidelity Management & Research, Flare Capital Partners, General Insuranceof India, Inova Health System, Longitude Capital Management Co, Optum Ventures, RA Capital Management and Wellington ManagementLLP’s $325m venture financing deal with Somatus, according to GlobalData’s deals database.

A total of 105 medical devices industry deals worth $2.2bn were announced for the region in February 2022, against the 12-month average of 108 deals.

Of all the deal types, venture financing saw most activity in February 2022 with 74 transactions, representing a 70.5% share for the region.

In second place was M&A with 22 deals, followed by private equity deals with nine transactions, respectively capturing a 21% and 8.6% share of the overall deal activity for the month.

In terms of value of deals, venture financing was the leading category in North America’s medical devices industry with $1.55bn, while private equity and M&A deals totalled $399.25m and $265.49m, respectively.

North America medical devices industry deals in February 2022: Top deals

The top five medical devices deals accounted for 49.5% of the overall value during February 2022.

The combined value of the top five medical devices deals stood at $1.1bn, against the overall value of $2.2bn recorded for the month.

The top five medical devices industry deals of February 2022 tracked by GlobalData were:

1) Anthem,Blue Venture Fund,Deerfield ManagementLP,Fidelity Management & Research,Flare Capital Partners,General Insuranceof India,Inova Health System,Longitude Capital Management Co,Optum Ventures,RA Capital Management and Wellington ManagementLLP $325m venture financing deal with Somatus

2) The $241m private equity of IntriCon by Altaris Capital Partners

3) Dreamtech $227.57m acquisition of 9.07% stake in Cardiac Insight

4) The $192m venture financing of Omada Health by aMoon Funds,Civilization Ventures,Fidelity Management & Research,Perceptive Advisors and Wellington ManagementLLP

5) Alumni Ventures Group,aMoon Funds,Cowen Healthcare Investments,Echo Health Ventures,Hitachi Ventures,Khosla Ventures,Laurion Capital Management,Monashee Investment Management,Neuberger Berman Group,Northpond Ventures and Optum Ventures $110m venture financing deal with Scipher Medicine